Novel dietary lipid-based self-nanoemulsifying drug delivery systems of paclitaxel with p-gp inhibitor: implications on cytotoxicity and biopharmaceutical performance

Bibliography

• Thanki K, Gangwal RP, Sangamwar AT, et al. Oral delivery of anticancer drugs: Challenges and opportunities. J Control Release 2013;170:15–40
   PubMed Web of Science ®Google Scholar
• Mazzaferro S, Bouchemal K, Ponchel G. Oral delivery of anticancer drugs I: General considerations. Drug Discov Today 2012;18:25–34
   PubMed Web of Science ®Google Scholar
• Beg S, Swain S, Rizwan M, et al. Bioavailability enhancement strategies: Basics, formulation approaches and regulatory considerations. Curr Drug Deliv 2011;8:691–702
   PubMed Web of Science ®Google Scholar
• Stuurman FE, Nuijen B, Beijnen JH, et al. Oral anticancer drugs: Mechanisms of low bioavailability and strategies for improvement. Clin Pharmacokinet 2013;52:399–414
   PubMed Web of Science ®Google Scholar
• Fasinu P, Pillay V, Ndesendo VM, et al. Diverse approaches for the enhancement of oral drug bioavailability. Biopharm Drug Dispos 2011;32:185–209
   PubMed Web of Science ®Google Scholar
• Mazzaferro S, Bouchemal K, Ponchel G. Oral delivery of anticancer drugs III: Formulation using drug delivery systems. Drug Discov Today 2012;18:99–104
   PubMed Web of Science ®Google Scholar
• Porter CJ, Wasan KM, Constantinides P. Lipid-based systems for the enhanced delivery of poorly water soluble drugs. Adv Drug Deliv Rev 2008;60:615–16
   PubMed Web of Science ®Google Scholar
• Porter CJ, Trevaskis NL, Charman WN. Lipids and lipid-based formulations: Optimizing the oral delivery of lipophilic drugs. Nat Rev Drug Discov 2007;6:231–48
   PubMed Web of Science ®Google Scholar
• Singh B, Bandopadhyay S, Kapil R, et al. Self-emulsifying drug delivery systems (SEDDS): Formulation development, characterization, and applications. Crit Rev Ther Drug Carrier Syst 2009;26:427–521
   PubMed Web of Science ®Google Scholar
• Beg S, Sandhu PS, Batra RS, et al. QbD-based systematic development of novel optimized solid self-nanoemulsifying drug delivery systems (SNEDDS) of lovastatin with enhanced biopharmaceutical performance. Drug Deliv 2014. [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Singh B, Beg S, Khurana RK, et al. Recent advances in self-emulsifying drug delivery systems (SEDDS). Crit Rev Ther Drug Carrier Syst 2014;31:121–85
   PubMed Web of Science ®Google Scholar
• Beg S, Jena SS, Patra Ch N, et al. Development of solid self-nanoemulsifying granules (SSNEGs) of ondansetron hydrochloride with enhanced bioavailability potential. Colloids Surf B Biointerfaces 2013;101:414–23
   PubMed Web of Science ®Google Scholar
• Kearns CM, Gianni L, Egorin MJ. Paclitaxel pharmacokinetics and pharmacodynamics. Semin Oncol 1995;22:16–23
   PubMed Web of Science ®Google Scholar
• Priyadarshini K, Keerthi Aparajitha U. Paclitaxel against cancer: A short review. Med Chem 2012;2:139–41
   Google Scholar
• Sonnichsen DS, Relling MV. Clinical pharmacokinetics of paclitaxel. Clin Pharmacokinet 1994;27:256–69
   PubMed Web of Science ®Google Scholar
• Zhang XN, Tang LH, Gong JH, et al. An alternative paclitaxel self-emulsifying microemulsion formulation: Preparation, pharmacokinetic profile, and hypersensitivity evaluation. PDA J Pharm Sci Technol 2006;60:89–94
   PubMedGoogle Scholar
• Oostendorp RL, Buckle T, Lambert G, et al. Paclitaxel in self-micro emulsifying formulations: oral bioavailability study in mice. Invest New Drugs 2010. [Epub ahead of print]
   Web of Science ®Google Scholar
• Gursoy N, Garrigue JS, Razafindratsita A, et al. Excipient effects on in vitro cytotoxicity of a novel paclitaxel self-emulsifying drug delivery system. J Pharm Sci 2003;92:2411–18
   PubMed Web of Science ®Google Scholar
• Veltkamp SA, Thijssen B, Garrigue JS, et al. A novel self-microemulsifying formulation of paclitaxel for oral administration to patients with advanced cancer. Br J Cancer 2006;95:729–34
   PubMed Web of Science ®Google Scholar
• Gao P, Rush BD, Pfund WP, et al. Development of a supersaturable SEDDS (S-SEDDS) formulation of paclitaxel with improved oral bioavailability. J Pharm Sci 2003;92:2386–98
   PubMed Web of Science ®Google Scholar
• Azeem A, Rizwan M, Ahmad FJ, et al. Nanoemulsion components screening and selection: a technical note. AAPS PharmSciTech 2009;10:69–76
   PubMed Web of Science ®Google Scholar
• Humberstone AJ, Charman WN. Lipid-based vehicles for the oral delivery of poorly water soluble drugs. Adv Drug Deliv Rev 1997;25:123–8
   Web of Science ®Google Scholar
• Abedi E, Sahari MA. Long-chain polyunsaturated fatty acid sources and evaluation of their nutritional and functional properties. Food Sci Nutr 2014;2:443–63
   PubMedGoogle Scholar
• Kajita M, Morishita M, Takayama K, et al. Enhanced enteral bioavailability of vancomycin using water-in-oil-in-water multiple emulsion incorporating highly purified unsaturated fatty acid. J Pharm Sci 2000;89:1243–52
   PubMed Web of Science ®Google Scholar
• Tiwari SB, Amiji MM. Improved oral delivery of paclitaxel following administration in nanoemulsion formulations. J Nanosci Nanotechnol 2006;6:3215–21
   PubMed Web of Science ®Google Scholar
• Vyas TK, Shahiwala A, Amiji MM. Improved oral bioavailability and brain transport of Saquinavir upon administration in novel nanoemulsion formulations. Int J Pharm 2008;347:93–101
   PubMed Web of Science ®Google Scholar
• Muchow M, Schmitz EI, Despatova N, et al. Omega-3 fatty acids-loaded lipid nanoparticles for patient-convenient oral bioavailability enhancement. Pharmazie 2009;64:499–504
   PubMed Web of Science ®Google Scholar
• Chaurasiya A, Singh AK, Jain GK, et al. Dual approach utilizing self microemulsifying technique and novel P-gp inhibitor for effective delivery of taxanes. J Microencasul 2012;29:583–95
   PubMed Web of Science ®Google Scholar
• Yang S, Gursoy RN, Lambert G, et al. Enhanced oral absorption of paclitaxel in a novel self-microemulsifying drug delivery system with or without concomitant use of P-glycoprotein inhibitors. Pharm Res 2004;21:261–70
   PubMed Web of Science ®Google Scholar
• Beg S, Swain S, Singh HP, et al. Development, optimization, and characterization of solid self-nanoemulsifying drug delivery systems of valsartan using porous carriers. AAPS PharmSciTech 2012;13:1416–27
   PubMed Web of Science ®Google Scholar
• Jain AK, Thanki K, Jain S. Solidified self-nanoemulsifying formulation for oral delivery of combinatorial therapeutic regimen: part I. Formulation development, statistical optimization, and in vitro characterization. Pharm Res 2013;31:923–45
   PubMed Web of Science ®Google Scholar
• Cook TJ, Shenoy SS. Intestinal permeability of chlorpyrifos using the single-pass intestinal perfusion method in the rat. Toxicology 2003;184:125–33
   PubMed Web of Science ®Google Scholar
• Yao J, Lu Y, Zhou JP. Preparation of nobiletin in self-microemulsifying systems and its intestinal permeability in rats. J Pharm Pharm Sci 2008;11:22–9
   PubMedGoogle Scholar
• Lennernas H. Human intestinal permeability. J Pharm Sci 1998;87:403–10
   PubMed Web of Science ®Google Scholar
• Zakeri-Milani P, Valizadeh H, Tajerzadeh H, et al. Predicting human intestinal permeability using single-pass intestinal perfusion in rat. J Pharm Pharm Sci 2007;10:368–79
   PubMed Web of Science ®Google Scholar
• Park JH, Hur HJ, Woo JS, et al. Effects of silymarin and formulation on the oral bioavailability of paclitaxel in rats. Eur J Pharm Sci 2011;45:296–301
   PubMed Web of Science ®Google Scholar
• Varma MV, Panchagnula R. Enhanced oral paclitaxel absorption with vitamin E-TPGS: Effect on solubility and permeability in vitro, in situ and in vivo. Eur J Pharm Sci 2005;25:445–53
   PubMed Web of Science ®Google Scholar
• Pawar YB, Purohit H, Valicherla GR, et al. Novel lipid based oral formulation of curcumin: Development and optimization by design of experiments approach. Int J Pharm 2012;436:617–23
   PubMed Web of Science ®Google Scholar
• O’Driscoll CM. Lipid-based formulations for intestinal lymphatic delivery. Eur J Pharm Sci 2002;15:405–15
   PubMed Web of Science ®Google Scholar
• Singh B, Singh R, Bandyopadhyay S, et al. Optimized nanoemulsifying systems with enhanced bioavailability of carvedilol. Colloids Surf B Biointerfaces 2012;101:465–74
   PubMed Web of Science ®Google Scholar
• Singh B, Khurana L, Bandyopadhyay S, et al. Development of optimized self-nano-emulsifying drug delivery systems (SNEDDS) of carvedilol with enhanced bioavailability potential. Drug Deliv 2011;18:599–612
   PubMed Web of Science ®Google Scholar
• Bandyopadhyay S, Katare OP, Singh B. Optimized self nano-emulsifying systems of ezetimibe with enhanced bioavailability potential using long chain and medium chain triglycerides. Colloids Surf B Biointerfaces 2012;100:50–61
   PubMed Web of Science ®Google Scholar
• Trautwein EA, Kunath-Rau A, Dietrich J, et al. Effect of dietary fats rich in lauric, myristic, palmitic, oleic or linoleic acid on plasma, hepatic and biliary lipids in cholesterol-fed hamsters. Br J Nutr 1997;77:605–20
   PubMed Web of Science ®Google Scholar
• Yu JN, Zhu Y, Wang L, et al. Enhancement of oral bioavailability of the poorly water-soluble drug silybin by sodium cholate/phospholipid-mixed micelles. Acta Pharmacol Sin 2010;31:759–64
   PubMed Web of Science ®Google Scholar
• Gershanik T, Benita S. Self-dispersing lipid formulations for improving oral absorption of lipophilic drugs. Eur J Pharm Biopharm 2000;50:179–88
   PubMed Web of Science ®Google Scholar
• Yan YD, Marasini N, Choi YK, et al. Effect of dose and dosage interval on the oral bioavailability of docetaxel in combination with a curcumin self-emulsifying drug delivery system (SEDDS). Eur J Drug Metab Pharmacokinet 2012;37:217–24
   PubMed Web of Science ®Google Scholar
• Tran TH, Guo Y, Song D, et al. Quercetin-containing self-nanoemulsifying drug delivery System for improving oral bioavailability. J Pharm Sci 2014;103:840–52
   PubMed Web of Science ®Google Scholar
• Nanjwade BK, Patel DJ, Udhani RA, et al. Functions of lipids for enhancement of oral bioavailability of poorly water-soluble drugs. Sci Pharm 2011;79:705–27
   PubMedGoogle Scholar
• Taha EI, Al-Suwayeh SA, El-Badry M. Bioavailability study of indomethacin self-nanemulsifying oral formulation in rats. Australian J Basic Appl Sci 2009;3(3):2944–8
   Google Scholar
• Shukla S, Zaher H, Hartz A, et al. Curcumin inhibits the activity of ABCG2/BCRP1, a multidrug resistance-linked ABC drug transporter in mice. Pharm Res 2009;26:480–7
   PubMed Web of Science ®Google Scholar
• Mohsin K. Design of lipid-based formulations for oral administration of poorly water-soluble drug fenofibrate: Effects of digestion. AAPS PharmSciTech 2012;13:637–46
   PubMed Web of Science ®Google Scholar